November 21, 2011 (New York, New York) — Three-year follow-up of the RESILIENT trial has shown that the LifeStent vascular stent (Bard Peripheral Vascular) leads to durable benefits and clinical ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio LAS VEGAS — A repuncturable vascular ...

In patients with common femoral artery disease, balloon angioplasty plus stenting if needed achieves acceptable restenosis and target lesion revascularization (TLR) rates at 1 year. The results render ...

Endovascular therapy, compared with surgery, was associated with significantly lower perioperative morbidity and mortality in patients with de novo atherosclerotic lesions of the common femoral artery ...

Cordis, a unit of Johnson & Johnson ($JNJ) is seeking an expanded indication for its SMART self-expanding stent, and the device performed well in patients with ...

The FDA today approved Cook Medical's Zilver PTX stent. It is the first drug-eluting stent (DES) approved for the treatment of peripheral arterial disease (PAD) in the superficial femoral and proximal ...

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical introduced the results from an aggregated data analysis at the Vascular Interventional Advances (VIVA) conference, highlighting the Zilver ® PTX ® Drug ...

LEIPZIG, GERMANY—What’s the best course of corrective action for obstructive lesions of the common femoral artery (CFA) caused by PAD? At LINC 2020, two experts took to the main stage to debate this ...

An aborted operation in La Jolla shows the true strength of an increasingly popular way to open blocked blood vessels. A Scripps Health cardiac team had planned to use a stent to clear a narrowed ...

Diagnosing coronary heart disease has been accomplished since the 1960s by coronary angiography. During the process, involving guiding a catheter tube through the body to the heart, contrast dye is ...